Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation

European Journal of Immunology

Volumn 33, Issue 1, 2003, Pages 125-134

  Contini, Paola ^a   Ghio, Massimo ^a   Poggi, Alessandro ^b   Filaci, Gilberto ^a   Indiveri, Francesco ^a   Ferrone, Soldano ^c   Puppo, Francesco ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Apoptosis; CD8; Fas ligand; HLA G; Soluble HLA

Indexed keywords

CD8 ANTIGEN; FAS ANTIGEN; FAS LIGAND; HLA A ANTIGEN; HLA ANTIGEN CLASS 1; HLA B ANTIGEN; HLA C ANTIGEN; HLA G ANTIGEN; T LYMPHOCYTE RECEPTOR;

ANTIBODY SPECIFICITY; ANTIGEN BINDING; ANTIGEN DETECTION; ANTIGEN PURIFICATION; APOPTOSIS; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EPSTEIN BARR VIRUS; GENETIC CODE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNE SYSTEM; IMMUNOMODULATION; IMMUNOREACTIVITY; IMMUNOREGULATION; IN VIVO STUDY; NATURAL KILLER CELL; NEOPLASM; PREGNANCY; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN SECRETION; REVIEW; SERUM; SUPERNATANT; T LYMPHOCYTE ACTIVATION; UPREGULATION;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD8; ANTIGENS, CD95; APOPTOSIS; CD8-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; FAS LIGAND PROTEIN; FLOW CYTOMETRY; HLA ANTIGENS; HUMANS; KILLER CELLS, NATURAL; MEMBRANE GLYCOPROTEINS; RNA, MESSENGER; SOLUBILITY; T-LYMPHOCYTES;

EID: 0037261143     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/immu.200390015     Document Type: Review

References (31)

1. Ploegh, H. L., Orr, H. T. and Strominger, J. L., Major histocompatibility antigens: The human (HLA-A, -B, -C) and murine (H-2 K, H-2D) class I molecules. Cell 1981. 24: 287-299.
2. O'Callaghan, C. A. and Bell, J. I., Structure and function of the human MHC class Ib molecules HLA-E, HLA-F and HLA-G. Immunol. Rev. 1998. 163: 129-138.
3. Ishitani, A. and Geraghty, D. E., Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II molecules. Proc. Natl. Acad. Sci. USA 1992. 89: 3947-3951.
4. Fujii, T., Ishitani, T. and Geraghty, D. E., A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4. J. Immunol. 1994. 153: 5516-5524.
5. Charlton, R. K. and Zmijewski, C. M., Soluble HL-A7 antigen: localization in the β-lipoprotein fraction of human serum. Science 1970. 170: 636-637.
6. Van Rood, J. J., van Leeuwen, A. and van Santen, M. C. T., Anti HL-A2 inhibitor in normal human serum. Nature 1970. 226: 366-367.
7. Rebmann, V., Pfeiffer, K., Pässler, M., Ferrone, S., Maier, S., Weiss, E. and Grosse-Wilde, H., Detection of soluble HLA-G molecules in plasma and amniotic fluid. Tissue Antigens 1999. 53: 14-22.
8. Hunt, J. S., Jadhav, L., Chu, W., Geraghty, D. E. and Ober, C., Soluble HLA-G circulates in maternal blood during pregnancy. Am. J. Obstet. Gynecol. 2000. 183: 682-688.
9. Pfeiffer, K. A., Rebmann, V., Pässler, M., van Der Van, K., van Der Ven, H., Krebs, D. and Grosse-Wilde, H., Soluble HLA levels in early pregnancy after in vitro fertilization. Hum. Immunol. 2000. 61: 559-564.
10. Puppo, F., Scudeletti, M., Indiveri, F. and Ferrone, S., Serum HLA class I antigens: markers and modulators of an immune response? Immunol. Today 1995. 16: 124-127.
11. Puppo, F., Indiveri, F., Scudeletti, M. and Ferrone, S., Soluble HLA antigens: new roles and uses. Immunol. Today 1997. 18: 154-155.
12. Tsuchiya, N., Shiota, M., Yamamuchi, A. and Ito, K., Elevated serum level of soluble HLA class I antigens in patients with systemic lupus erythematosus. Arthritis Rheum. 1996. 39: 792-796.
13. Ugurel, S., Rebmann, V., Ferrone, S., Tilgen, W., Grosse-Wilde, H., Reinhold, U., Soluble human leukocyte antigen-G serum level is elevated in melanoma patients and is further increased by interferon-alpha immunotherapy. Cancer 2001. 92: 369-376.
14. Dal Porto, J., Johansen, T. E., Catipovic, B., Parfiit, D. J., Tuveson, D., Gether, U., Kozlowski, S., Fearon, D. T. and Schneck, J. P., A soluble divalent class I major histocompatibility complex molecule inhibits alloreactive T cells at nanomolar concentrations. Proc. Natl. Acad. Sci. USA 1993. 90: 6671-6675.
15. Hausmann, R., Zavazava, N., Steinmann, J. and Müller-Ruchholtz, W., Interaction of papain-digested HLA class I molecules with human alloreactive cytotoxic T lymphocytes (CTL). Clin. Exp. Immunol. 1993. 91: 183-188.
16. Zavazava, N. and Krönke, M., Soluble HLA class I molecules induce apoptosis in alloreactive cytotoxic T lymphocytes. Nature Med. 1996. 2: 1005-1010.
17. + T lymphocytes. Int. Immunol. 2000. 12: 195-203.
18. + cells by interaction with CD8. J. Immunol. 2000. 164: 6100-6104.
19. + T cell regulatory mechanism. Proc. Natl. Acad. Sci. USA 2001. 98: 12150-12155.
20. Hansen, B., Janssen, E., Machleidt, T., Krönke, M. and Zavazava, N., Purified truncated recombinant HLA-B7 molecules abrogate cell function in alloreactive cytotoxic T lymphocytes by apoptosis induction. Transplantation 1998. 66: 1818-1822.
21. Smith, M. A., Naziruddin, B., Poindexter, N. J., Haynes, A. E., Howard, T. and Mohanakumar, T., Liver transplant recipent sera derived soluble HLA mediates allele specific CTL apoptosis. Transplantation 2000. 69: 157-162.
22. + cytotoxic T lymphocytes by Fas/Fas-ligand interaction. Hum. Immunol. 2000. 61: 1347-1351.
23. Xu, X. N., Purbhoo, M. A., Chen, N., at. al., A novel approach to antigen-specific deletion of CTL with minimal cellular activation using α3 domain mutants of MHC class I/peptide complex. Immunity 2001. 14: 591-602.
24. Barnstable, C. J., Bodmer, W. F., Brown, G., Galfre, G., Milstein, C., Williams, A. F. and Ziegler, A. Z., Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens: new tools for genetic analysis. Cell 1978. 14: 9-20.
25. Tanabe, M., Sekimata, M., Ferrone, S. and Takiguchi, M., Structural and functional analysis of monomorphic determinants recognized by monoclonal antibodies reacting with the HLA class I α3 domain. J. Immunol. 1992. 148: 3202-3209.
26. Pellegrino, M. A., Ng, A. K., Russo, C. and Ferrone, S., Heterogeneous distribution of determinants defined by monoclonal antibodies on HLA-A and B antigens bearing molecules. Transplantation 1982. 34: 18-23.
27. Lee, N., Malacko, A. R., Ishitani, A., Chen, M. C., Bajorath, J., Marquardt, H. and Geraghty, D. E., The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association. Immunity 1995. 3: 591-600.
28. Böyum, A., Separation of leukocytes from blood and bone marrow. Scand. J. Clin. Lab. Invest. 1968. 21 (Suppl. 97): 77-89.
29. Spaggiari, G. M., Contini, P., Carosio, R., Arvigo, M., Ghio, M., Oddone, D., Dondero, A., Zocchi, M. R., Puppo, F., Indiveri, F. and Poggi, A., Soluble HLA class I molecules induce natural killer cell apoptosis through the engagement of CD8. Evidence for a negative regulation exerted by CD94/NKG2A complex and KIR2D. Blood 2002. 99: 1706-1714.
30. Russo, C., Pellegrino, M. A. and Ferrone, S., A double determinant immunoassay with monoclonal antibodies to the HLA-A, B, C complex. Transpl. Proc. 1983. 15: 66-67.
31. Gavioli, R., de Campos-Lima, P. O., Kurilla, M. G., Kieff, E., Klein, G. and Masucci, M. G., Recognition of the Epstein-Barr virus-encoded nuclear antigens EBNA-4 and EBNA-6 by HLA-A11-restricted cytotoxic T lymphocytes: Implications for downregulation of HLA-A11 in Burkitt lymphoma. Proc. Natl. Acad. Sci. USA 1992. 89: 5862-5866.